Previous Article | Next Article ![]()
Journal of Virology, November 1998, p. 8597-8604, Vol. 72, No. 11
Departments of Microbiology and Immunology
1 and
Pediatrics3
and
Elizabeth B. Lamb Center for Pediatric
Research,2 Vanderbilt University School of
Medicine, Nashville, Tennessee 37232
Received 9 March 1998/Accepted 6 July 1998
The reovirus Reoviruses contain a genome
consisting of 10 discrete segments of double-stranded RNA
(44). Each gene segment is monocistronic with the exception
of the S1 gene, which encodes two proteins, viral attachment protein
The existence of the 14-kDa The To characterize the role of Cells and viruses.
Spinner-adapted murine L929 (L) cells
were grown in either suspension or monolayer cultures in Joklik's
modified Eagle medium (Irvine Scientific, Santa Ana, Calif.) as
previously described (9). Madin-Darby canine kidney (MDCK)
cells were grown in modified Eagle's medium (Gibco BRL, Gaithersburg,
Md.) that was supplemented to contain 10% fetal bovine serum
(Intergen, Purchase, N.Y.), 2 mM L-glutamine, 100 U of
penicillin per ml, 100 µg of streptomycin per ml, and 250 ng of
amphotericin per ml (Irvine). Spodoptera frugiperda cells
(Sf21 and High 5) (Clontech Laboratories, Palo Alto, Calif.) were grown
in Grace's insect cell medium (Gibco) supplemented to contain 10%
fetal bovine serum, 2 mM L-glutamine, 50 U of penicillin
per ml, and 50 µg of streptomycin per ml. Sp2/0-Ag14 myeloma cells
(American Type Culture Collection, Rockville, Md.) and hybridoma cells
were grown in Dulbecco's modified Eagle medium (Gibco) supplemented to
contain either 10% (DMEM-10) or 20% (DMEM-20) fetal bovine serum, 20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES) (Gibco), 1 mM sodium pyruvate (Gibco), 0.1 mM nonessential amino acids (Gibco), 2 mM L-glutamine, 100 U of penicillin
per ml, 100 µg of streptomycin per ml, and 250 ng of amphotericin per
ml. Hybridoma cells were selected in DMEM-20 containing 0.1 mM
hypoxanthine, 0.4 µM aminopterin, and 16 µM thymidine (HAT medium;
Sigma, St. Louis, Mo.) and subcloned in DMEM-20 supplemented to contain
5% Hybridoma Cloning Factor (Igen, Gaithersburg, Md.).
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Reovirus Growth in Cell Culture Does Not Require
the Full Complement of Viral Proteins: Identification of a
1s-Null Mutant
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
1s protein is a 14-kDa nonstructural protein
encoded by the S1 gene segment. The S1 gene has been linked to many
properties of reovirus, including virulence and induction of apoptosis.
Although the function of
1s is not known, the
1s open reading
frame is conserved in all S1 gene sequences determined to date. In this
study, we identified and characterized a variant of type 3 reovirus,
T3C84-MA, which does not express
1s. To facilitate these
experiments, we generated two monoclonal antibodies (MAbs) that bind
different epitopes of the
1s protein. Using these MAbs in immunoblot
and immunofluorescence assays, we found that L929 (L) cells infected
with T3C84-MA do not contain
1s. To determine whether
1s is
required for reovirus infection of cultured cells, we compared the
growth of T3C84-MA and its parental strain, T3C84, in L cells and
Madin-Darby canine kidney (MDCK) cells. After 48 h of growth,
yields of T3C84-MA were equivalent to yields of T3C84 in L cells and
were fivefold lower than yields of T3C84 in MDCK cells. After 7 days of
growth following adsorption at a low multiplicity of infection, yields
of T3C84-MA and T3C84 did not differ significantly in either L cells or
MDCK cells. To determine whether
1s is required for apoptosis
induced by reovirus infection, T3C84-MA and T3C84 were tested for their
capacity to induce apoptosis, using an acridine orange staining assay.
In these experiments, the percentages of apoptotic cells following
infection with T3C84-MA and T3C84 were equivalent. These findings
indicate that nonstructural protein
1s is not required for reovirus
growth in cell culture and does not influence the capacity of reovirus
to induce apoptosis. Therefore, reovirus replication does not require
the full complement of virally encoded proteins.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
1 and nonstructural protein
1s, in overlapping open reading
frames (ORFs) (15, 21, 37). Studies using reassortant
viruses to investigate mechanisms of reovirus pathogenesis indicate
that the S1 gene segregates with strain-specific differences in
reovirus growth in the intestine (4, 24), pathway of spread
in the host (24, 25, 45), tropism for neural tissues
(25, 50, 51), inhibition of DNA synthesis, (39,
46), and induction of apoptosis (35, 46, 47). In addition, mutations in the S1 gene are selected during persistent reovirus infections of cultured cells (23, 52, 55). For most
properties linked to the S1 gene, a direct association with the
1
protein has been deduced by the demonstration that a particular phenotype is determined by viral attachment (9, 31, 42, 51)
or by the identification of mutations in the deduced amino acid
sequence of
1 without an attendant change in
1s (2). For other S1-mediated properties, an association with
1 is inferred from studies using UV-irradiated virions (39, 40, 47), which are incapable of expressing
1s. Thus, previous studies of reovirus properties associated with the S1 gene have not provided insight into
the function or importance of nonstructural protein
1s.
1s protein was first predicted upon the
discovery that two discrete translation initiation sites on s1 mRNAs
were protected by ribosomes in RNase protection assays (27).
Polyclonal antisera raised to peptides corresponding to predicted
antigenic regions of
1s were used to demonstrate by both
immunoprecipitation and immunofluorescence that
1s is expressed in
murine L929 (L) cells infected with type 3 reovirus and that
1s has
a cytoplasmic localization (8). Studies of the kinetics of
1s expression indicate that
1s appears in reovirus-infected cells
8 to 12 h postinfection (6, 21). Additional work
suggests that
1s also is capable of translocation into the nucleus
(3).
1s ORF is maintained in every S1 gene sequence determined to
date and varies from 119 to 125 amino acids in length (1, 2, 7, 9,
12, 14, 29, 30, 32, 55). Alignments of
1s-deduced amino acid
sequences of prototype reovirus strains type 1 Lang (T1L), type 2 Jones, and type 3 Dearing (T3D) demonstrate that
1s is highly
divergent among strains of the three reovirus serotypes, sharing only
18 identical amino acid positions (14). Among 11 serotype 3 reovirus isolates, deduced amino acid sequences of
1s share 59%
sequence identity (12). The only region of
1s conserved
among all S1 gene sequences of the type 3 strains analyzed thus far is
a highly basic region of approximately 8 to 12 amino acids near the
amino terminus (7, 12, 30).
1s in the reovirus life cycle, a variant
of type 3 reovirus that does not express
1s was identified and
studied. Two hybridomas expressing anti-
1s monoclonal antibodies (MAbs) were isolated, and these antibodies were used to confirm that
1s is not expressed by the viral variant during infection of
cultured cells. The requirement of
1s for reovirus growth and
cellular injury was determined in assays of viral yield and apoptosis
induction. Results of these studies represent the first description of
a viable reovirus null mutant.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
Expression and purification of epitope-tagged
1s.
A cDNA
of the T3D reovirus S1 gene segment was generated by reverse
transcriptase PCR amplification of purified reovirus
double-stranded RNA, using primers specific for the noncoding regions
of the S1 gene as previously described (9). The S1 cDNA was
cloned into the pCR2.1 vector (Invitrogen, San Diego, Calif.), and this
construct, termed pCR2.1-S1, was used as a template to amplify the
1s ORF in subsequent PCRs. The octapeptide FLAG epitope tag (Kodak,
New Haven, Conn.) was appended to the amino terminus of
1s by PCR amplification of the
1s ORF, using primers containing FLAG-encoding sequences. This PCR product was cloned into the pCR2.1 vector and then
subcloned into the pBacPAK8 transfer vector (Clontech). Fidelity of the
cDNA encoding the FLAG-
1s fusion protein was confirmed by dideoxy
chain-termination sequencing. Linearized BacPAK6 baculovirus genomic
DNA (Clontech) and the recombinant pBacPAK8 transfer vector were
cotransfected into Sf21 cells. Baculovirus recombinants arising from
the cotransfection were plaque purified on Sf21 cell monolayers, and
second-passage lysate stocks of recombinant baculovirus were generated
by using Sf21 cells. The FLAG-
1s fusion protein was expressed in
High 5 cells infected with recombinant virus. Expressed
1s protein
in cell lysates was recovered using an affinity gel containing
FLAG-specific MAb M2 (Kodak). After washing, fusion protein-containing
affinity gel was heated at 100°C for 5 min in Laemmli sample buffer
(28) and FLAG-
1s protein was resolved using a preparative
14% polyacrylamide gel. Bands corresponding to FLAG-
1s (~15 kDa)
were excised and electroeluted. The eluate was dialyzed against 150 mM
Tris-HCl (pH 7.4) and concentrated using a Centricon filter (10,000 molecular weight cutoff) (Amicon, Beverly, Mass.).
Expression and purification of
1s as a fusion with MBP.
The pCR2.1-S1 construct was used to amplify the
1s ORF by PCR, and
PCR products encoding full-length or truncated
1s proteins were
subcloned into the pMAL-c2 vector (New England Biolabs, Beverly, Mass.). Three maltose-binding protein (MBP)-
1s constructs were generated: MBP plus full-length
1s (MBP-
1s/1-120), MBP plus
1s amino acids 1 to 84 (MBP-
1s/1-84), and MBP plus
1s amino acids 1 to 42 (MBP-
1s/1-42). The fidelity of cDNAs encoding the MBP-
1s fusion proteins was confirmed by dideoxy chain-termination sequencing. Recombinant pMAL-c2 vectors were used to transform Escherichia coli DH5
, which was induced to express the
fusion protein by the addition of 0.3 mM
isopropyl-
-D-thiogalactopyranoside. After 3 to 4 h
of growth, cells were pelleted by centrifugation and resuspended in
column buffer (20 mM Tris-HCl [pH 7.4], 200 mM NaCl, 1 mM EDTA).
Cells were lysed by sonication, and cellular debris was removed by
centrifugation. Fusion proteins were purified by affinity
chromatography using an amylose resin (New England Biolabs).
Indirect ELISA.
Detection of
1s-specific antibodies was
performed by enzyme-linked immunosorbent assay (ELISA), using
FLAG-
1s fusion protein as antigen. EIA/RIA plates (Costar,
Cambridge, Mass.) were coated with 100 ng of FLAG-
1s per ml and
incubated with primary antibody (cell culture supernatants or serum).
Horseradish peroxidase-conjugated sheep anti-mouse secondary antibody
(Amersham, Arlington Heights, Ill.) was incubated with FLAG-
1s and
primary antibody, followed by the addition of
2,2'-azinobis(3-ethylbenzthiazoline)-sulfonic acid substrate (Sigma).
Color reactions were quantitated in a Titertek Multiscan Plus ELISA
plate reader (Flow Laboratories, McLean, Va.) at a wavelength of 405 nm.
Generation and characterization of anti-
1s MAbs.
BALB/c
mice were inoculated intraperitoneally with 50 µg of MBP-
1s fusion
protein combined with Ribi adjuvant (RIBI, Hamilton, Mont.). Booster
inoculations were given every 3 weeks, and anti-
1s antibody
titers were monitored by indirect ELISA with FLAG-
1s fusion protein
as antigen. Once antibody titers exceeded 1:1,000 by ELISA, mice were
boosted with MBP-
1s in the absence of adjuvant and spleens were
harvested 3 days later. Spleen cells were fused with Sp2/0-Ag14 myeloma
cells using polyethylene glycol 4000 (Merck, Gibbstown, N.J.), and the
products of each fusion were cultured on murine peritoneal macrophage
feeder layers in HAT medium. When hybridomas were 10 to 20% confluent,
supernatants from each colony were screened for anti-
1s antibodies
by indirect ELISA using FLAG-
1s fusion protein as antigen. Cells
from antibody-positive colonies were subcloned by limiting dilution.
When subcloned colonies were 10 to 20% confluent, supernatants were
again screened for anti-
1s antibodies by indirect ELISA. Hybridoma
cells secreting anti-
1s antibodies were injected into the peritoneum
of BALB/c mice, and ascitic fluid was harvested. MAbs were purified
using Econo-Pac protein-A chromatography columns (Bio-Rad). Isotyping was performed using a capture ELISA hybridoma subtyping kit
(Boehringer-Mannheim, Indianapolis, Ind.).
Immunoblot analysis of reovirus proteins. L cells were adsorbed with reovirus strains at a multiplicity of infection (MOI) of 10 PFU per cell. After 0 to 28 h of incubation at 37°C, cytoplasmic extracts were prepared by washing cells in phosphate-buffered saline (PBS) followed by incubation in hypotonic lysis buffer (10 mM HEPES [pH 7.9], 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and a protease inhibitor cocktail [5 µg of antipain per ml, 5 µg of aprotinin per ml, 5 µg of leupeptin per ml, 0.5 µg of pepstatin per ml, 7.5 µg of bestatin per ml, 4 µg of phosphoramidon per ml, and 5 µg of soybean trypsin inhibitor per ml]) at 4°C for 15 min. Nonidet P-40 was added to a final concentration of 0.65% (vol/vol), samples were vortexed, and cell membranes and nuclei were pelleted by centrifugation.
Protein extracts from L cells were electrophoresed in either 14% sodium dodecyl sulfate-polyacrylamide gels (28) (100 µg of total protein per lane) or 16.5% Tris-Tricine Ready Gels (Bio-Rad), transferred to a nitrocellulose membrane, and preincubated in a solution of Tris-buffered saline (TBS) containing 0.05% Tween-20 and 5% low-fat dry milk. The membrane was incubated with 5 µg of primary antibody per ml diluted in TBS plus Tween-20 and milk. After washing three times in TBS plus Tween-20, the membrane was incubated with horseradish peroxidase-conjugated sheep anti-mouse secondary antibody (Amersham) diluted 1:2,500 in TBS plus Tween-20 and milk. The membrane was washed three times in TBS plus Tween-20, incubated with enhanced chemiluminescent reagent (Amersham), and exposed to Biomax MR film (Kodak).Immunofluorescence of reovirus-infected L cells.
L
cells were grown on 12-mm glass coverslips (VWR Scientific, Atlanta,
Ga.) for 2 days prior to infection. Cells were adsorbed with
reovirus strains at an MOI of 10 PFU per cell at room
temperature for 1 h. After 12 h of incubation at 37°C,
cells were washed with PBS and fixed for 2 min in a 1:1 mixture of
methanol and acetone. Cells were washed three times with PBS and
incubated 10 min in PBS containing 1% Triton X-100 (PBS/Triton).
Nonspecific binding of antibody to cells was blocked by incubation with
2% normal goat serum (NGS) diluted in PBS/Triton (PBS/Triton/NGS).
Cells were then incubated for 45 min with anti-
1s primary antibody (50 µg per ml diluted in PBS/Triton/NGS). After three washes in PBS/Triton/NGS, cells were incubated with biotinylated goat anti-mouse immunoglobulin G2a (IgG2a) (diluted 1:1,000 in PBS/Triton/NGS) (Amersham) for 45 min. Cells were washed three times in PBS/Triton/NGS and incubated with streptavidin-Cy2 conjugate (Amersham) (diluted 1:1,000 in PBS/Triton/NGS), TO-PRO-3 (Molecular Probes, Eugene, Ore.) (1:1,000), and anti-
NS MAb 2H7 cross-linked to Cy3 (10 µg
per ml) for 45 min. Cy2, Cy3, and TO-PRO-3 were visualized separately
with excitation at 488, 543, and 643 nm, respectively, using a Zeiss
LSM 410 confocal microscope equipped with a 63× Plan-Apochromat 1.4 NA
oil-immersion objective lens. Images were processed using Adobe
Photoshop 4.0.
Quantitation of reovirus growth in L cells and MDCK
cells.
Cells (2 × 105 cells) grown in 24-well
tissue-culture plates (Costar) were infected with reovirus
strains at MOIs of 0.001 or 10 PFU per cell. Following viral adsorption
for 1 h, the inoculum was removed, 1.0 ml of fresh medium was
added, and cells were incubated at 37°C for defined intervals. Cells
and culture media were frozen (
70°C) and thawed twice, and virus
contained in cell lysates was titrated on L-cell monolayers by plaque
assay (48). In experiments to determine viral titer in cell
lysates and cell supernatants, cell culture medium was removed and
replaced with an equal volume of PBS prior to freezing of cells.
Quantitation of apoptosis by AO staining. L cells (2 × 105 cells) grown in 24-well tissue culture plates were infected with reovirus strains at an MOI of 100 PFU per cell. The percentage of apoptotic cells was determined by acridine orange (AO) staining as previously described (13, 35, 47). Briefly, cells were washed in PBS and incubated with trypsin-EDTA (Irvine). Cell culture medium, the PBS wash, and trypsinized cells were combined and centrifuged. The cell pellet was resuspended in approximately 25 µl of cell culture medium and stained with 2 µl of a solution containing 100 µg of AO (Sigma) per ml and 100 µg of ethidium bromide (Sigma) per ml. The percentage of cells exhibiting condensed chromatin was determined by epiillumination fluorescence microscopy using a fluorescein filter set (Nikon).
| |
RESULTS |
|---|
|
|
|---|
Identification of a
1s-null reovirus variant.
Reovirus strain T3C84, isolated from a human host in 1961 (12,
36), does not bind to or grow in MEL cells. Serial passage of
T3C84 in MEL cells was used to select a viral variant that efficiently
infects these cells (9). MEL-adapted viruses were plaque
purified, and the S1 gene nucleotide sequence of a tenth-passage isolate (T3C84-MA) was determined. The S1 gene sequence of this strain was found to contain two point mutations (Fig.
1A). One of these is a U to C transition
at nucleotide position 616, which results in a tryptophan to arginine
substitution at amino acid position 202 in the
1 protein (Fig. 1A,
Point Mutation #1). The tryptophan to arginine mutation occurs in a
region of
1 important for its binding to the reovirus
receptor on MEL cells, sialic acid (9, 11). The other point
mutation in the T3C84-MA S1 gene is an A to U transversion at
nucleotide position 89 (Fig. 1A, Point Mutation #2). This mutation
results in a lysine to isoleucine substitution at amino acid position
26 in
1 and the introduction of a stop codon following amino acid
position 6 in
1s (Fig. 1B).
|
Generation and characterization of anti-
1s MAbs.
To
determine whether
1s is expressed in cells infected with
T3C84-MA, MAbs were generated for use in immunoblot and
immunofluorescence assays. Recombinant
1s protein was expressed as a
fusion protein with the FLAG epitope (FLAG-
1s) in insect cells using
a baculovirus expression system and with MBP (MBP-
1s) in E. coli. Mice were immunized with MBP-
1s and monitored by ELISA,
using FLAG-
1s as antigen, for production of antibodies against
1s. Using this strategy, two
1s-specific IgG2a MAbs, 2F4 and 3E2,
were obtained that are capable of immunoblotting, immunostaining, and
immunoprecipitating
1s from cells infected with type 3 reovirus.
1s protein, full-length or truncated forms of
1s were expressed
as fusion proteins with MBP (Fig. 2A) and
used as targets in immunoblot assays (Fig. 2B). MAb 2F4 recognized
only the full-length
1s fusion protein, MBP-
1s/1-120, and did
not bind either of the truncation mutants, MBP-
1s/1-84 or
MBP-
1s/1-42. These data suggest that MAb 2F4 recognizes an epitope
containing sequences in the carboxy-terminal one-third of
1s (amino
acids 85 to 120). MAb 3E2 recognized the full-length
1s fusion
protein and truncation mutant MBP-
1s/1-84 but did not bind
MBP-
1s/1-42. These findings suggest that the epitope recognized by
MAb 3E2 contains sequences from the middle portion of
1s (amino
acids 43 to 84) but not the carboxy-terminal one-third. Thus,
1s-specific MAbs 2F4 and 3E2 bind discrete antigenic regions of the
1s protein.
|
1s MAbs to detect virally
encoded
1s and to define the kinetics of
1s expression in
reovirus-infected cells, L cells were infected with T3D, and immunoblotting with MAbs 2F4 and 3E2 was performed using cell lysates
prepared at various intervals after infection (Fig.
3 and data not shown). The results
demonstrate that
1s expression is detectable in T3D-infected cells
by 8 h postinfection, consistent with previously published
findings (21). Thus, MAbs generated against an MBP-
1s
fusion protein bind native
1s produced in reovirus-infected
cells.
|
Determination of
1s expression in T3C84- and T3C84-MA-infected
cells.
Sequence analysis of the T3C84-MA S1 gene suggested that
1s would not be expressed by this strain due to the presence of a
termination codon following amino acid position 6 in the
1s ORF. To
confirm that T3C84-MA is incapable of expressing
1s, anti-
1s MAb
2F4 was used to assess
1s expression by immunoblot analysis (Fig.
3). Expression of
1s was detected in T3D-infected and T3C84-infected
L cells by 8 and 12 h postinfection, respectively; however,
1s
was not detected in T3C84-MA-infected L cells throughout the 28-h time
course (Fig. 3). As a control for efficient infection of the cells, MAb
8H6 (49) was used to determine the levels of expression of
structural protein µ1/µ1C (Fig. 3). The findings demonstrate that
µ1/µ1C was efficiently expressed in cells infected with all three
virus strains by 8 to 12 h postinfection. Identical results were
obtained using
1s-specific MAb 3E2 in experiments to assess
1s
expression in T3C84-MA-infected cells (data not shown). To exclude the
possibility that downstream initiation products of
1s are expressed
in cells infected with T3C84-MA, lysates of T3D-, T3C84-, and
T3C84-MA-infected L cells were resolved in a 16.5% Tris-Tricine gel
and subjected to immunoblot analysis using MAb 2F4. No polypeptides
smaller than full-length
1s were detected in cells infected with the
three virus strains (data not shown). These results demonstrate that
neither full-length
1s nor downstream initiation products of
1s
are expressed in cells infected with T3C84-MA.
1s, immunofluorescence staining for
1s in
reovirus-infected cells was performed by using confocal
microscopy. L cells were either mock infected or infected with T3D,
T3C84, or T3C84-MA and stained with anti-
1s MAb 2F4 at 12 h
postinfection (Fig. 4). Cells also were
stained with anti-
NS MAb 2H7 (19) as a control for
reovirus infection. Using this technique,
1s and
NS were
detected in T3D-infected and T3C84-infected cells, but only
NS was
detected in T3C84-MA-infected cells. To determine whether
1s is
capable of translocation to the nucleus,
reovirus-infected cells also were stained with TO-PRO-3, a
nuclear dye (data not shown). In cells infected with either T3D
or T3C84,
1s was distributed throughout the cytoplasm and also was
detected in the nucleus, overlapping in distribution with TO-PRO-3;
1s was not concentrated at perinuclear sites of virus assembly
(17, 34, 38). These data are consistent with immunoblot
analyses of lysates obtained from reovirus-infected L cells and
indicate that cells infected with T3C84-MA do not express
1s.
|
Growth of T3C84 and T3C84-MA in L cells and MDCK cells.
To assess the importance of
1s in reovirus
replication, strains T3C84 and T3C84-MA were used to infect L
fibroblast cells and MDCK epithelial cells. Virus was adsorbed to both
cell types at an MOI of 10 PFU per cell, and virus titers were
determined in cell lysates at various times postadsorption (Fig.
5). After 48 h of growth in L cells,
both T3C84 and T3C84-MA produced titers of approximately 5 × 108 PFU per ml, representing greater than a 1,000-fold
increase in viral yield. Furthermore, T3C84 and T3C84-MA
demonstrated identical growth kinetics in L cells during the
assay period and displayed no significant differences in plaque
morphology. In MDCK cells, T3C84 and T3C84-MA produced titers of
1.1 × 108 and 2.2 × 107 PFU per ml,
respectively, after 48 h of growth. These findings suggest that the
1s protein is not required for reovirus
growth in cell culture but that expression of
1s may provide a
slight growth advantage in MDCK cells.
|
Growth of T3C84 and T3C84-MA in L cells and MDCK cells after viral
adsorption at a low MOI.
To further assess whether
1s confers
any advantage to reovirus replication in L cells or MDCK cells,
T3C84 and T3C84-MA were adsorbed to cells at an MOI of 0.001 PFU per
cell and viral titers were determined at 24-h intervals for 7 days
(Fig. 6). We reasoned that if
1s were
responsible for a small contribution to viral growth, then a difference
in viral yield might be apparent in L cells after several cycles of
infection, and the fivefold difference observed in MDCK cells would be
enhanced. After 7 days of viral growth in L cells, T3C84 and T3C84-MA
reached titers of 8.6 × 107 and 5.2 × 107 PFU per ml, respectively. In MDCK cells, T3C84 and
T3C84-MA reached maximal titers of 2.7 × 104 and
3.5 × 104 PFU per ml, respectively, over a 7-day
growth period. Therefore, after several cycles of viral replication,
expression of the
1s protein does not confer a discernible growth
advantage in either L cells or MDCK cells.
|
Yields of cell-free virus from cells infected with T3C84 and
T3C84-MA.
In the experiments described above, viral yields
were determined by titrating virus from lysates of infected
cells. To determine whether
1s plays a role in release of
progeny virions from cells infected with reovirus, L cells were
adsorbed with either T3C84 or T3C84-MA at an MOI of 10 PFU per cell and
virus titers were determined for both culture supernatants and cell
lysates at various times postadsorption (Fig.
7). After 48 h of growth, T3C84 and T3C84-MA produced titers of approximately 7.5 × 107
and 5.9 × 107 PFU per ml, respectively, in culture
supernatants and 7.3 × 107 and 1.9 × 108 PFU per ml, respectively, in cell lysates. Moreover,
T3C84 and T3C84-MA did not differ in the kinetics of viral release as
judged by accumulation of viral titer in culture supernatants over
time. Thus, the
1s protein is not required for efficient release of progeny virions from reovirus-infected cells.
|
Apoptosis induction by T3C84 and T3C84-MA in L cells.
Differences in the capacity of reovirus strains to induce
apoptosis in L cells (46, 47) and MDCK cells (35)
have been mapped to the S1 gene segment, which encodes both viral
attachment protein
1 and nonstructural protein
1s. To directly
assess the role of
1s in apoptosis, L cells were infected with
reovirus strains T3C84 and T3C84-MA and apoptosis was
quantitated using an AO staining assay (13, 47) (Fig.
8). AO is a fluorescent dye
that allows cells undergoing apoptosis to be identified by the presence
of condensed chromatin. T3C84 and T3C84-MA induced equivalent
levels of apoptosis using this assay. This result indicates that
the
1s protein is not required for apoptosis induction by reovirus.
|
| |
DISCUSSION |
|---|
|
|
|---|
Reovirus nonstructural protein
1s has no known function,
although it is expressed at detectable levels during reovirus
infection of cultured cells (6, 21) (Fig. 3 and 4). The fact
that the
1s ORF is conserved in every S1 gene sequence reported to
date, representing 28 independent reovirus isolates (1, 2,
7, 9, 12, 14, 29, 30, 32, 55), suggests that
1s confers some
selective advantage to reovirus replication and plays an important biological role. Examination of the deduced amino acid sequences of nonstructural proteins of other members of the
Reoviridae family does not reveal a homologue for the
1s
protein (10). Moreover, protein database searches (GenBank
CDS translations, Brookhaven Protein Data Bank, SwissProt, and Protein
Information Resource) do not identify proteins with significant primary
sequence similarity to
1s (10). Thus, the deduced amino
acid sequence of
1s does not lead to obvious inferences about its
function.
The purpose of this study was to investigate the role of the
1s
protein in reovirus infection by characterizing a type 3 reovirus variant, T3C84-MA, that does not express
1s.
Reovirus strain T3C84-MA was isolated in a study of receptor-binding
mutants of field isolate strains of type 3 reovirus.
Nucleotide sequence analysis of the T3C84-MA S1 gene suggested that
1s would not be expressed in cells infected with this variant
(9). Consistent with this prediction, full-length or
truncated forms of
1s were not detected in T3C84-MA-infected
L cells using immunoblot (Fig. 3 and data not shown) and
immunofluorescence (Fig. 4) assays. These findings are in contrast to
those obtained using either parental strain T3C84 or prototype strain
T3D in which
1s was found by immunofluorescence to be distributed
throughout the cytoplasm and was detected at low levels in the nucleus.
The finding that
1s is capable of nuclear translocation in
reovirus-infected cells confirms the results of a previous
study that demonstrated nuclear localization of
1s in COS cells
transfected with
1s (3).
Our findings clearly show that
1s expression is not required for
reovirus growth in cultured cells. Yields of T3C84 and T3C84-MA following adsorption at an MOI of 10 PFU per cell were equivalent after
48 h of growth in L cells (Fig. 5A) and differed minimally after
48 h of growth in MDCK cells (Fig. 5B). As a more stringent means
to assess the possible contributions of
1s to reovirus growth in cell culture, we compared the yields of T3C84 and T3C84-MA in
L cells and MDCK cells after several cycles of viral replication, following infection at a low MOI. In these experiments, we again found
no significant differences in yields of T3C84 and T3C84-MA in either
cell type (Fig. 6). We also performed experiments to test whether
1s
contributes to the release of progeny virions from
reovirus-infected cells. Similar to the results obtained in assays of viral growth, we found no difference between T3C84 and T3C84-MA in the kinetics or quantity of virus
released into culture supernatants of infected cells (Fig. 7).
Therefore, these results indicate that
1s is dispensable for
reovirus growth in cell culture and demonstrate that
reovirus infection of cultured cells does not require the full
complement of viral proteins.
Identification of T3C84-MA afforded the opportunity to directly test
whether
1s influences apoptosis induction by reovirus. In
previous studies of reovirus-induced apoptosis of L cells and MDCK cells, differences in the capacity of type 1 and type 3 reovirus strains to induce apoptosis were linked by using
reassortant viruses to the S1 gene (35, 46, 47).
UV-irradiated reovirus virions, which are incapable of
mediating viral protein synthesis (40), induce apoptosis
efficiently (47), which suggests that
1s is not involved
in apoptosis induction. Concordantly, in the context of productive
reovirus infection, T3C84-MA and its parent, T3C84, induced
equivalent levels of apoptosis as determined by AO staining (Fig. 8).
In a previous study, overexpression of T3D
1s in murine C127 cells
appeared to increase the cytopathicity of T1L and T3D (16),
suggesting that the
1s protein plays a role in
reovirus-induced cell death. However, our findings indicate
that apoptosis, which serves as an important mechanism of
reovirus-induced cytopathicity in cell culture (35, 46,
47) and in vivo (33), is not affected by the absence
of
1s protein. These results support the hypothesis that
1, and
not
1s, is the S1 gene product responsible for mediating differences
in the capacity of reovirus strains to induce apoptosis.
Since
1s is not required for reovirus infection of cultured
cells or for the induction of apoptosis, strict retention of the
1s
ORF strongly suggests that the
1s protein is important for viral
growth or spread in vivo. There are ample precedents for viral proteins
that are not required for growth in cultured cells yet play important
roles in virus-host interactions (reviewed in reference 53). For
example, the adenovirus E3 19-kDa protein is dispensable for viral
replication in cultured cells (26) but modulates the host
immune response by blocking cell surface expression of major
histocompatibility complex (MHC) class I antigens (5).
Similarly, the human cytomegalovirus US11 gene product, though not
required for efficient growth in cell culture (22), down
regulates MHC class I expression by targeting these molecules for
proteosomal degradation (54). If
1s plays an important role in reovirus replication in vivo, a
1s-negative strain
such as T3C84-MA would be expected to display altered virulence in comparison to wild-type reovirus. Because T3C84-MA and its
parental strain, T3C84, also differ in the capacity to bind sialylated receptors (9), differences in the pathogenicity of these
strains are not necessarily attributable to
1s function. To
address this issue, we currently are attempting to isolate a
variant of T3C84 that binds sialic acid and retains the
1s
ORF.
Studies of other members of the Reoviridae family indicate that these viruses can tolerate genomic deletions and rearrangements yet retain the capacity to replicate in cell culture, albeit with less efficiency than wild-type viruses. For example, nondefective rotavirus strains have been described with deletions, truncations, or rearrangements of gene 5, which encodes NSP1 (20, 41, 43). In each of these cases, rotaviruses expressing truncated or rearranged NSP1 proteins exhibit reduced viral yields or decreased plaque size, suggesting that NSP1 affects the efficiency of viral growth. To our knowledge, reovirus strain T3C84-MA represents the first viable null mutant of mammalian reovirus and the first null mutant of the Reoviridae family without a detectable defect in viral growth.
Results presented here establish that reovirus nonstructural
protein
1s is not required for efficient viral growth in cell culture, making it unique among reovirus proteins. These
results also suggest that the
1s protein plays a role in
virus-host interactions in vivo. Our future studies will focus on
the delineation of
1s-mediated effects on viral replication,
cytopathology, and pathogenesis in mammalian hosts.
| |
ACKNOWLEDGMENTS |
|---|
We are grateful to Geoff Baer, Mehmet Goral, Larry Kerr, Aaron Shatkin, Paul Spearman, and Ken Tyler for expert advice. Guidance in the production of MAbs was provided by Randy Emmons. We thank Chris Aiken, Erik Barton, Patrick Green, and Denise Wetzel for careful reviews of the manuscript.
This work was supported by Public Health Service award T32 GM07347 from the National Institute of General Medical Studies for the Vanderbilt Medical Scientist Training Program (S.E.R.), Public Health Service award AI38296 from the National Institute of Allergy and Infectious Diseases, and the Elizabeth B. Lamb Center for Pediatric Research. Additional support was provided by Public Health Service awards P60 DK20593 for the Vanderbilt Diabetes Research and Training Center and CA68485 and DK20593 for the Vanderbilt Cell Imaging Resource.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Lamb Center for Pediatric Research, D7235 MCN, Vanderbilt University School of Medicine, Nashville, TN 37232. Phone: (615) 343-9943. Fax: (615) 343-9723. E-mail: terry.dermody{at}mcmail.vanderbilt.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Bassel-Duby, R., A. Jayasuriya, D. Chatterjee, N. Sonenberg, J. V. Maizel, Jr., and B. N. Fields. 1985. Sequence of reovirus haemagglutinin predicts a coiled-coil structure. Nature 315:421-423[Medline]. |
| 2. |
Bassel-Duby, R.,
D. R. Spriggs,
K. L. Tyler, and B. N. Fields.
1986.
Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique.
J. Virol.
60:64-67 |
| 3. | Belli, B. A., and C. E. Samuel. 1991. Biosynthesis of reovirus-specified polypeptides: expression of reovirus S1 encoded sigma 1NS protein in transfected and infected cells as measured with serotype specific polyclonal antibody. Virology 185:698-709[Medline]. |
| 4. |
Bodkin, D. K., and B. N. Fields.
1989.
Growth and survival of reovirus in intestinal tissue: role of the L2 and S1 genes.
J. Virol.
63:1188-1193 |
| 5. |
Burgert, H.,
J. Maryanski, and S. Kvist.
1987.
"E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens.
Proc. Natl. Acad. Sci. USA
84:1356-1360 |
| 6. |
Cashdollar, L. W.,
P. Blair, and S. Van Dyne.
1989.
Identification of the 1s protein in reovirus serotype 2-infected cells with antibody prepared against a bacterial fusion protein.
Virology
168:183-186[Medline].
|
| 7. |
Cashdollar, L. W.,
R. A. Chmelo,
J. R. Wiener, and W. K. Joklik.
1985.
Sequences of the S1 genes of the three serotypes of reovirus.
Proc. Natl. Acad. Sci. USA
82:24-28 |
| 8. | Ceruzzi, M., and A. J. Shatkin. 1986. Expression of reovirus p14 in bacteria and identification in the cytoplasm of infected mouse L cells. Virology 153:35-45[Medline]. |
| 9. |
Chappell, J. D.,
V. L. Gunn,
J. D. Wetzel,
G. S. Baer, and T. S. Dermody.
1997.
Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein 1.
J. Virol.
71:1834-1841[Abstract].
|
| 10. | Connolly, J. L., and T. S. Dermody. Unpublished observation. |
| 11. |
Dermody, T. S.,
M. L. Nibert,
R. Bassel-Duby, and B. N. Fields.
1990.
A 1 region important for hemagglutination by serotype 3 reovirus strains.
J. Virol.
64:5173-5176 |
| 12. |
Dermody, T. S.,
M. L. Nibert,
R. Bassel-Duby, and B. N. Fields.
1990.
Sequence diversity in S1 genes and S1 translation products of 11 type 3 reovirus strains.
J. Virol.
64:4842-4850 |
| 13. | Duke, R. C., and J. J. Cohen. 1992. Morphological and biochemical assays of apoptosis, p. 17.1-17.16. In J. E. Coligan (ed.), Current protocols in immunology. Wiley & Sons, New York, N.Y. |
| 14. | Duncan, R., D. Horne, L. W. Cashdollar, W. K. Joklik, and P. W. Lee. 1990. Identification of conserved domains in the cell attachment proteins of the three serotypes of reovirus. Virology 174:399-409[Medline]. |
| 15. |
Ernst, H., and A. J. Shatkin.
1985.
Reovirus hemagglutinin mRNA codes for two polypeptides in overlapping reading frames.
Proc. Natl. Acad. Sci. USA
82:48-52 |
| 16. | Fajardo, K. E., and A. J. Shatkin. 1990. Expression of the two reovirus S1 gene products in transfected mammalian cells. Virology 178:223-231[Medline]. |
| 17. | Fields, B. N., C. S. Raine, and S. G. Baum. 1971. Temperature-sensitive mutants of reovirus type 3: defects in viral maturation as studied by immunofluorescence and electron microscopy. Virology 43:569-578[Medline]. |
| 18. |
Furlong, D. B.,
M. L. Nibert, and B. N. Fields.
1988.
Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles.
J. Virol.
62:246-256 |
| 19. | Goral, M. I., G. S. Baer, P. R. Hazelton,
S. E. Rodgers, K. M. Coombs, and T. S. Dermody.
Reovirus non-structural protein NS localizes to viral inclusions and
is required for viral assembly. Submitted for publication.
|
| 20. | Hua, J., and J. T. Patton. 1994. The carboxyl-half of the rotavirus nonstructural protein NS53 (NSP1) is not required for virus replication. Virology 198:567-576[Medline]. |
| 21. | Jacobs, B. L., and C. E. Samuel. 1985. Biosynthesis of reovirus-specified polypeptides: the reovirus S1 mRNA encodes two primary translation products. Virology 143:63-74[Medline]. |
| 22. |
Jones, T.,
V. Muzithras, and Y. Gluzman.
1991.
Replacement mutagenesis of the human cytomegalovirus genome: US10 and US11 gene products are nonessential.
J. Virol.
65:5860-5872 |
| 23. | Kauffman, R. S., R. Ahmed, and B. N. Fields. 1983. Selection of a mutant S1 gene during reovirus persistent infection of L cells: role in maintenance of the persistent state. Virology 131:79-87[Medline]. |
| 24. | Kauffman, R. S., J. L. Wolf, R. Finberg, J. S. Trier, and B. N. Fields. 1983. The sigma 1 protein determines the extent of spread of reovirus from the gastrointestinal tract of mice. Virology 124:403-410[Medline]. |
| 25. |
Kaye, K. M.,
D. R. Spriggs,
R. Bassel-Duby,
B. N. Fields, and K. L. Tyler.
1986.
Genetic basis for altered pathogenesis of an immune-selected antigenic variant of reovirus type 3 Dearing.
J. Virol.
59:90-97 |
| 26. |
Kelly, T., and A. Lewis.
1973.
Use of nondefective adenovirus-simian virus 40 hybrids for mapping the simian virus 40 genome.
J. Virol.
12:643-652 |
| 27. | Kozak, M. 1982. Analysis of ribosome binding sites from the S1 message of reovirus. Initiation at the first and second AUG codons. J. Mol. Biol. 156:807-820[Medline]. |
| 28. | Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[Medline]. |
| 29. | Munemitsu, S. M., J. A. Atwater, and C. E. Samuel. 1986. Biosynthesis of reovirus-specified polypeptides. Molecular cDNA cloning and nucleotide sequence of the reovirus serotype 1 Lang strain bicistronic s1 mRNA which encodes the minor capsid polypeptide sigma 1a and the nonstructural polypeptide sigma 1bNS. Biochem. Biophys. Res. Commun. 140:508-514[Medline]. |
| 30. |
Nagata, L.,
S. A. Masri,
D. C. Mah, and P. W. K. Lee.
1984.
Molecular cloning and sequencing of the reovirus (serotype 3) S1 gene which encodes the viral cell attachment protein 1.
Nucleic Acids Res.
12:8699-8710 |
| 31. |
Nibert, M. L.,
J. D. Chappell, and T. S. Dermody.
1995.
Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved 1 protein.
J. Virol.
69:5057-5067[Abstract].
|
| 32. |
Nibert, M. L.,
T. S. Dermody, and B. N. Fields.
1990.
Structure of the reovirus cell-attachment protein: a model for the domain organization of 1.
J. Virol.
64:2976-2989 |
| 33. | Oberhaus, S. M., R. L. Smith, G. H. Clayton, T. S. Dermody, and K. L. Tyler. 1997. Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J. Virol. 71:2100-2106[Abstract]. |
| 34. | Rhim, J. S., L. E. Jordan, and H. D. Mayor. 1962. Cytochemical, fluorescent-antibody and electron microscopic studies on the growth of reovirus (ECHO 10) in tissue culture. Virology 17:342-355[Medline]. |
| 35. | Rodgers, S. E., E. S. Barton, S. M. Oberhaus, B. Pike, C. A. Gibson, K. L. Tyler, and T. S. Dermody. 1997. Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J. Virol. 71:2540-2546[Abstract]. |
| 36. | Rosen, L., J. F. Hovis, F. M. Mastrota, J. A. Bell, and R. J. Huebner. 1960. Observations on a newly recognized virus (Abney) of the reovirus family. Am. J. Hyg. 71:258-265. [Medline] |
| 37. |
Sarkar, G.,
J. Pelletier,
R. Bassel-Duby,
A. Jayasuriya,
B. N. Fields, and N. Sonenberg.
1985.
Identification of a new polypeptide coded by reovirus gene S1.
J. Virol.
54:720-725 |
| 38. | Sharpe, A. H., L. B. Chen, and B. N. Fields. 1982. The interaction of mammalian reoviruses with the cytoskeleton of monkey kidney CV-1 cells. Virology 120:399-411[Medline]. |
| 39. |
Sharpe, A. H., and B. N. Fields.
1981.
Reovirus inhibition of cellular DNA synthesis: role of the S1 gene.
J. Virol.
38:389-392 |
| 40. |
Shaw, J. E., and D. C. Cox.
1973.
Early inhibition of cellular DNA synthesis by high multiplicities of infectious and UV-irradiated reovirus.
J. Virol.
12:704-710 |
| 41. | Taniguchi, K., K. Kojima, and S. Urasawa. 1996. Nondefective rotavirus mutants with an NSP1 gene which has a deletion of 500 nucleotides, including a cysteine-rich zinc finger motif-encoding region (nucleotides 156 to 248), or which has a nonsense codon at nucleotides 153 to 155. J. Virol. 70:4125-4130[Abstract]. |
| 42. | Tardieu, M., M. L. Powers, and H. L. Weiner. 1983. Age-dependent susceptibility to reovirus type 3 encephalitis: role of viral and host factors. Ann. Neurol. 13:602-607[Medline]. |
| 43. |
Tian, Y.,
O. Tarlow,
A. Ballard,
U. Desselberger, and M. A. McCrae.
1993.
Genomic concatemerization/deletion in rotaviruses: a new mechanism for generating rapid genetic change of potential epidemiological importance.
J. Virol.
67:6625-6632 |
| 44. | Tyler, K. L., and B. N. Fields. 1996. Reoviruses, p. 1597-1623. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa. |
| 45. |
Tyler, K. L.,
D. A. McPhee, and B. N. Fields.
1986.
Distinct pathways of viral spread in the host determined by reovirus S1 gene segment.
Science
233:770-774 |
| 46. | Tyler, K. L., M. K. T. Squier, A. L. Brown, B. Pike, D. Willis, S. M. Oberhaus, T. S. Dermody, and J. J. Cohen. 1996. Linkage between reovirus-induced apoptosis and inhibition of cellular DNA synthesis: role of the S1 and M2 genes. J. Virol. 70:7984-7991[Abstract]. |
| 47. |
Tyler, K. L.,
M. K. T. Squier,
S. E. Rodgers,
B. E. Schneider,
S. M. Oberhaus,
T. A. Grdina,
J. J. Cohen, and T. S. Dermody.
1995.
Differences in the capacity of reovirus strains to induce apoptosis are determined by viral attachment protein 1.
J. Virol.
69:6972-6979[Abstract].
|
| 48. |
Virgin, H. W., IV,
R. Bassel-Duby,
B. N. Fields, and K. L. Tyler.
1988.
Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing).
J. Virol.
62:4594-4604 |
| 49. |
Virgin, H. W., IV,
M. A. Mann,
B. N. Fields, and K. L. Tyler.
1991.
Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action.
J. Virol.
65:6772-6781 |
| 50. |
Weiner, H. L.,
D. Drayna,
D. R. Averill, Jr., and B. N. Fields.
1977.
Molecular basis of reovirus virulence: role of the S1 gene.
Proc. Natl. Acad. Sci. USA
74:5744-5748 |
| 51. | Weiner, H. L., M. L. Powers, and B. N. Fields. 1980. Absolute linkage of virulence and central nervous system tropism of reoviruses to viral hemagglutinin. J. Infect. Dis. 141:609-616[Medline]. |
| 52. | Wetzel, J. D., G. J. Wilson, G. S. Baer, L. R. Dunnigan, J. P. Wright, D. S. H. Tang, and T. S. Dermody. 1997. Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly. J. Virol. 71:1362-1369[Abstract]. |
| 53. | Whitton, J. L., and M. B. A. Oldstone. 1996. Immune responses to viruses, p. 345-374. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa. |
| 54. | Wiertz, E., T. Jones, L. Sun, M. Bogyo, H. Geuze, and H. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769-779[Medline]. |
| 55. |
Wilson, G. J.,
J. D. Wetzel,
W. Puryear,
R. Bassel-Duby, and T. S. Dermody.
1996.
Persistent reovirus infections of L cells select mutations in viral attachment protein 1 that alter oligomer stability.
J. Virol.
70:6598-6606 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»